Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Humana (NY:HUM)

230.83 UNCHANGED
Streaming Delayed Price Updated: 7:00 PM EDT, Jun 4, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Humana

< Previous 1 2 3 4 5 6 7 8 9
...
43 44 Next >
Ponce University Textbooks For Biology, Digital Download E-Books Announced
Via Press Release Distribution Service
Humana Stock In Focus After Firm Announces CFO Transition, Reiterates EPS Guidance: Retail ’s Bullish
Incoming CFO Celeste Mellet currently serves as the CFO of infrastructure fund manager Global Infrastructure Partners. 
Via Stocktwits
Humana Announces CFO Transition
From Humana Inc.
Via Business Wire
10 Worst Performing Large-Caps Last 12 Months
Over the past twelve months ten Large-Cap stocks have underperformed all others. 
Via Talk Markets
Topics Stocks / Equities
(HUM) - Analyzing Humana's Short Interest
Via Benzinga
UnitedHealth Rises On Medicare Star Ratings Ruling; Humana Rallies
A federal judge ordered a rerating of the its Medicare Advantage star ratings. Humana also rallied. 
Via Investor's Business Daily
Unpacking the Latest Options Trading Trends in Humana
Via Benzinga
The Latest Analyst Ratings For Humana
Via Benzinga
If You Invested $100 In This Stock 15 Years Ago, You Would Have $700 Today
Via Benzinga
Large-Cap Stocks In Trouble - Saturday, Nov. 23
Over the past 12 months, a group of 10 large-cap stocks have underperformed all others. Here’s an updated look at the top 10 worst performing large-caps, along with their one-year price returns. 
Via Talk Markets
Topics Stocks / Equities
Deal Dispatch: Starbucks Considers China Sale, Private Equity Bankrupts Snack Company, Darwin Financial Talks Mining
Darwin Financial's Joshua Robinson talks to Benzinga about the firm's latest commodities deal, and more M&A news from this past week. 
Via Benzinga
Large-Cap Stocks In Trouble - Sunday, Nov. 17
Over the past 12 months, a group of 10 large-cap stocks have underperformed all others. Here’s an updated look at the top 10 worst performing large-caps, along with their one-year price returns. 
Via Talk Markets
Unpacking the Latest Options Trading Trends in Humana
Via Benzinga
Deal Dispatch: Shell, Unilever And More Are On The Sell Side; The Onion Makes Alex Jones Cry Foul
Evolent Health, Kronos Bio, Saint-Gobain, Shell and Unilever are on the sell-side this week. Benzinga's Deal Dispatch has the latest M&A updates. 
Via Benzinga
Humana Appoints Michelle O'Hara as Chief Human Resources Officer
From Humana Inc.
Via Business Wire
Humana Recognized for Commitment to Veteran Employment by Military Times and Military Friendly®
From Humana Inc.
Via Business Wire
Cigna’s Stock Surges After Dropping Humana Merger Plans
Cigna Group has decided not to merge with Humana, leading to a rise in Cigna's stock and a drop in Humana's stock. 
Via Talk Markets
Cigna Not Pursuing Humana Merger, Stock Soars
Cigna Group reaffirms 2024 EPS outlook, reports strong Q3 results, and clarifies it is not pursuing a merger with Humana amid ongoing speculation. 
Via Benzinga
Donald Trump's Second Term Could Reshape US Healthcare System, With Major Impacts on Affordable Care Act And Medicare
Trump's second term could bring significant changes to U.S. healthcare, with cuts to ACA subsidies and potential Medicare privatization. 
Via Benzinga
Topics Government
Exposures Political
Humana and Evolent Expand Partnership to Enhance Oncology Care
From Evolent Health, Inc.
Via Business Wire
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
MarketBeat Week in Review – 10/28 - 11/1
Stocks staged a strong rally on Friday following a steep sell-off; a weak jobs report all but guarantees a rate cut which adds to bullish sentiment 
Via MarketBeat
Topics Artificial Intelligence Economy
Exposures Artificial Intelligence Interest Rates
Humana Lifts 2024 Profit Outlook As Q3 Earnings Beat Street View On Medicare Strength
Humana's Q3 EPS of $4.16 beat estimates but fell year-over-year. Revenue rose to $29.3 billion, driven by Medicare Advantage growth. 2024 guidance raised. 
Via Benzinga
Topics Earnings
Exposures Financial
Humana Reports Third Quarter 2024 Financial Results; Updates Full Year Adjusted 2024 Financial Guidance
From Humana Inc.
Via Business Wire
HUM INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation Into Humana Inc. and Encourages Investors to Contact the Firm
From Bronstein, Gewirtz & Grossman, LLC
Via Business Wire
Cigna Considers Humana Acquisition – What It Means for the Stocks
Rumors swirl around a potential Cigna (CI) and Humana (HUM) merger, but Medicare Advantage costs pose a significant challenge, making the merger risky. 
Via MarketBeat
HUM INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation Into Humana Inc. and Encourages Investors to Contact the Firm
From Bronstein, Gewirtz & Grossman, LLC
Via Business Wire
Large-Cap Stocks In Trouble - Sunday, Oct. 27
Here’s this week’s top 10 worst performing Large-Caps in the last twelve months. 
Via Talk Markets
Humana Board Declares Payment of Quarterly Dividend to Stockholders
From Humana Inc.
Via Business Wire
Humana Named “Best-of-the-Best” Company for Supplier Diversity by the National LGBT Chamber of Commerce
From Humana Inc.
Via Business Wire
< Previous 1 2 3 4 5 6 7 8 9
...
43 44 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.